Emmanuelle Ferrant

Early-onset invasive aspergillosis and other fungal infections in patients treated with ibrutinib

David Ghez, Anne Calleja, Caroline Protin et al. · Blood · 2018 · 288 citations · Full text

Baseline metabolic tumour volume is an independent prognostic factor in Hodgkin lymphoma

Salim Kanoun, Cédric Rossi, Alina Berriolo-Riedinger et al. · European Journal of Nuclear Medicine and Molecular Imaging · 2014 · 175 citations

Tumor Biology, Lymphoid Neoplasia, Hodgkin Lymphoma +8

The Reversed Halo Sign: Pathognomonic Pattern of Pulmonary Mucormycosis in Leukemic Patients With Neutropenia?

C. Legouge, Denis Caillot, Marie‐Lorraine Chrétien et al. · Clinical Infectious Diseases · 2013 · 167 citations

Commercial <scp>anti‐CD19 CAR</scp> T cell therapy for patients with relapsed/refractory aggressive B cell lymphoma in a European center

Pierre Sesques, Emmanuelle Ferrant, Violaine Safar et al. · American Journal of Hematology · 2020 · 130 citations · Full text

Cell Therapy, Immunology, Immunoediting +20

6 months versus 12 months of adjuvant trastuzumab in early breast cancer (PHARE): final analysis of a multicentre, open-label, phase 3 randomised trial

Xavier Pivot, Gilles Romieu, Marc Debled et al. · The Lancet · 2019 · 125 citations

Breast Oncology, Oncology, Early Breast Cancer +6